Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSV-ZEBOV (Ervebo) Safety and Immunogenicity in Healthy Adults
NCT02287480Phase 2Completed
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Ebola Zaire vaccine (live, attenuated) in Ebola virus disease (EVD). Started Nov 2014; status: completed.
02
Drugs
Ebola Zaire vaccine (live, attenuated)
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT02287480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287480.